Investor · 3 deals
Every published round Australian Unity took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| OncoRes Medical | Series A | Apr 2022 | $9.5m | Lead | Brandon Capital portfolio (Wed 2 Nov 2022), Brandon BioCatalyst portfolio (Wed 2 Nov 2022), Brandon Capital portfolio (Wed 18 May 2022), Brandon BioCatalyst portfolio (Wed 18 May 2022), Startup News (WA) | |
| Baymatob | Series A | 23 Mar 2022 | $4.6m | Participant | Alberts Impact Ventures, Alberts Impact Ventures portfolio (Thu 24 Nov 2022), Alberts Impact Ventures portfolio (Wed 23 Mar 2022) | |
| Planet Innovation | Unnamed stage | 4 Dec 2020 | ~$10m | Participant | @AuManufacturing (Wed 14 Jul 2021), @AuManufacturing (Fri 4 Dec 2020) |
Companies Australian Unity has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Planet Innovation | 4 Dec 2020 | 1 | 0 | |
| Baymatob | 23 Mar 2022, Series A | 1 | 0 | |
| OncoRes Medical | Apr 2022, Series A | 1 | 1 |
Fund closes reported for Australian Unity, as distinct from the investments it has made.
Companies Australian Unity has backed that another company then bought. An exit for the holding, not a deal Australian Unity did.
Stories naming Australian Unity. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Former Optus CEO Kelly Bayer Rosmarin warns rogue AI agents in enterprises are inevitable and discusses Aigentsphere, her AI-monitoring startup, which raised a $4 million seed round from Main Sequence in April.
Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.
Also movefm.com.au
Aura Group has appointed Dino Pesce, a financial services sales veteran, as Head of Origination in its Property Credit team, where he will help expand lending for commercial asset purchases.
Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.
Clear Dynamics has closed a $35m Series B led by existing backers OIF Ventures and Colinton Capital Partners, with new family office and private investment, to fund international expansion of its AI enterprise software.
Also OIF Ventures portfolio·Centerstone Capital portfolio·Startup Daily
Alberts announces investment in Baymatob, whose Oli device predicts birth timing and detects hemorrhages, as the first deal in its Equality theme; CEO Tara Croft cites Australian Unity among capital partners in the raise.
Also Alberts Impact Ventures portfolio·Alberts Impact Ventures portfolio
Cancer-detection nanotech developer Ferronova announced a $3.5 million Series A round, with Uniseed leading, to fund planned human trials across several cancer types; research partners span four universities.